Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

490 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer.
Dal Pra A, Dirix P, Khoo V, Carrie C, Cozzarini C, Fonteyne V, Ghadjar P, Gomez-Iturriaga A, Panebianco V, Zapatero A, Bossi A, Wiegel T. Dal Pra A, et al. Among authors: bossi a. Clin Transl Radiat Oncol. 2023 May 9;41:100638. doi: 10.1016/j.ctro.2023.100638. eCollection 2023 Jul. Clin Transl Radiat Oncol. 2023. PMID: 37251620 Free PMC article. Review.
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management.
Sacco M, Gandaglia G, Aas K, Ceci F, Chiu P, Fankhauser CD, Fournier G, Heiddeger I, Kasivisvanathan V, Kesch C, Maggi M, Martini A, Olivier J, Ploussard G, Preisser F, Puche-Sanz I, Rajwa P, Soeterik T, Thibault C, Valerio M, van den Bergh RCN, Zattoni F, Rivas JG, Moschini M, Gillessen S, Bossi A, Gontero P, Marra G; YAU Prostate Cancer Working Group. Sacco M, et al. Among authors: bossi a. Clin Genitourin Cancer. 2023 Jun;21(3):416.e1-416.e10. doi: 10.1016/j.clgc.2022.11.012. Epub 2022 Dec 5. Clin Genitourin Cancer. 2023. PMID: 36609130
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group.
Ka K, Schiappa R, Terlizzi M, Mallet F, Martin E, Chand ME, Demogeot N, Peiffert D, Pommier P, Quivrin M, Kissel M, Pasquier C, Khalifa J, Bossi A, Hannoun-Levi JM, Blanchard P. Ka K, et al. Among authors: bossi a. Radiother Oncol. 2023 Mar;180:109460. doi: 10.1016/j.radonc.2022.109460. Epub 2023 Jan 10. Radiother Oncol. 2023. PMID: 36638842
490 results